Geron GERN
NASDAQ GERN
$1.57 +0.02 (+1.29%)
As of: Aug 21, 2026 · 11:11 AM EDT

Geron (GERN) Total Current Liabilities (2010 - 2026)

Geron (GERN) posted Total Current Liabilities of $73.6 million for Q1 2026, down 34.04% sequentially from $111.5 million in Q4 2025, and up 16.71% YoY from $63.0 million in Q1 2025.

Geron (GERN) Total Current Liabilities (2010 - 2026) Analysis & Trends

Geron has reported Total Current Liabilities for 17 years, with the latest figure at $73.6 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 16.71% year-over-year to $73.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.6 million (up 16.71% YoY) and the FY2025 annual result came in at $111.5 million, up 26.32% from the prior year.
  • Total Current Liabilities retreated to $73.6 million in Q1 2026 per GERN's latest filing, from $111.5 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $137.9 million in Q3 2024 and troughed at $43.9 million in Q1 2023.
  • A 5-year average of $83.5 million and a median of $82.8 million in 2022 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 180.47% in 2024, then tumbled 48.82% in 2025.
  • Over 5 years, Total Current Liabilities stood at $76.7 million in 2022, then surged by 40.91% to $108.1 million in 2023, then slipped by 18.3% to $88.3 million in 2024, then gained by 26.32% to $111.5 million in 2025, then sank by 34.04% to $73.6 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $73.6 million, $111.5 million, and $87.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 140.01 Bn 132.16 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn 1.58 Bn
4 Moderna 60.18 Bn 55.04 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 31.55 Bn 28.24 Bn 992.69 Mn 1.51 Bn
7 BioNTech SE 28.45 Bn 10.06 Bn 668.28 Mn 2.49 Bn
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn 438.74 Mn
9 Royalty Pharma 27.19 Bn 26.36 Bn - 630.93 Mn
10 Geron 1.05 Mn -299.80 Mn - 70.33 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 70.33 Mn
Mar 31, 2026 73.57 Mn
Dec 31, 2025 111.54 Mn
Sep 30, 2025 87.71 Mn
Jun 30, 2025 64.28 Mn
Mar 31, 2025 63.03 Mn
Dec 31, 2024 88.30 Mn
Sep 30, 2024 137.93 Mn
Jun 30, 2024 103.54 Mn
Mar 31, 2024 123.16 Mn
Dec 31, 2023 108.07 Mn
Sep 30, 2023 89.39 Mn
Jun 30, 2023 72.57 Mn
Mar 31, 2023 43.91 Mn
Dec 31, 2022 76.69 Mn
Sep 30, 2022 82.81 Mn
Jun 30, 2022 46.88 Mn
Mar 31, 2022 46.63 Mn
Dec 31, 2021 45.52 Mn
Sep 30, 2021 38.47 Mn